Literature DB >> 27219867

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains.

Terry D Crawford1, Vickie Tsui1, E Megan Flynn1, Shumei Wang1, Alexander M Taylor2, Alexandre Côté2, James E Audia2, Maureen H Beresini1, Daniel J Burdick1, Richard Cummings2, Les A Dakin2, Martin Duplessis2, Andrew C Good2, Michael C Hewitt2, Hon-Ren Huang2, Hariharan Jayaram2, James R Kiefer1, Ying Jiang3, Jeremy Murray1, Christopher G Nasveschuk2, Eneida Pardo2, Florence Poy2, F Anthony Romero1, Yong Tang2, Jian Wang3, Zhaowu Xu3, Laura E Zawadzke2, Xiaoyu Zhu3, Brian K Albrecht2, Steven R Magnuson1, Steve Bellon2, Andrea G Cochran1.   

Abstract

The biological role played by non-BET bromodomains remains poorly understood, and it is therefore imperative to identify potent and highly selective inhibitors to effectively explore the biology of individual bromodomain proteins. A ligand-efficient nonselective bromodomain inhibitor was identified from a 6-methyl pyrrolopyridone fragment. Small hydrophobic substituents replacing the N-methyl group were designed directing toward the conserved bromodomain water pocket, and two distinct binding conformations were then observed. The substituents either directly displaced and rearranged the conserved solvent network, as in BRD4(1) and TAF1(2), or induced a narrow hydrophobic channel adjacent to the lipophilic shelf, as in BRD9 and CECR2. The preference of distinct substituents for individual bromodomains provided selectivity handles useful for future lead optimization efforts for selective BRD9, CECR2, and TAF1(2) inhibitors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27219867     DOI: 10.1021/acs.jmedchem.6b00264

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2).

Authors:  Terry D Crawford; James E Audia; Steve Bellon; Daniel J Burdick; Archana Bommi-Reddy; Alexandre Côté; Richard T Cummings; Martin Duplessis; E Megan Flynn; Michael Hewitt; Hon-Ren Huang; Hariharan Jayaram; Ying Jiang; Shivangi Joshi; James R Kiefer; Jeremy Murray; Christopher G Nasveschuk; Arianne Neiss; Eneida Pardo; F Anthony Romero; Peter Sandy; Robert J Sims; Yong Tang; Alexander M Taylor; Vickie Tsui; Jian Wang; Shumei Wang; Yongyun Wang; Zhaowu Xu; Laura Zawadzke; Xiaoqin Zhu; Brian K Albrecht; Steven R Magnuson; Andrea G Cochran
Journal:  ACS Med Chem Lett       Date:  2017-06-01       Impact factor: 4.345

Review 2.  Biological function and histone recognition of family IV bromodomain-containing proteins.

Authors:  Jonathan T Lloyd; Karen C Glass
Journal:  J Cell Physiol       Date:  2017-06-13       Impact factor: 6.384

3.  Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.

Authors:  David Remillard; Dennis L Buckley; Hyuk-Soo Seo; Fleur M Ferguson; Sirano Dhe-Paganon; James E Bradner; Nathanael S Gray
Journal:  ACS Med Chem Lett       Date:  2019-09-13       Impact factor: 4.345

Review 4.  Structural features and inhibitors of bromodomains.

Authors:  Jamel Meslamani; Steven G Smith; Roberto Sanchez; Ming-Ming Zhou
Journal:  Drug Discov Today Technol       Date:  2016-09-22

Review 5.  Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.

Authors:  Nilesh Zaware; Ming-Ming Zhou
Journal:  Curr Opin Chem Biol       Date:  2017-07-06       Impact factor: 8.822

6.  Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors.

Authors:  Michael A Clegg; Natalie H Theodoulou; Paul Bamborough; Chun-Wa Chung; Peter D Craggs; Emmanuel H Demont; Laurie J Gordon; Gemma M Liwicki; Alex Phillipou; Nicholas C O Tomkinson; Rab K Prinjha; Philip G Humphreys
Journal:  ACS Med Chem Lett       Date:  2021-08-03       Impact factor: 4.632

7.  In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4.

Authors:  Yoel Rodríguez; Guillermo Gerona-Navarro; Roman Osman; Ming-Ming Zhou
Journal:  Proteins       Date:  2019-10-21

8.  Large-scale analysis of water stability in bromodomain binding pockets with grand canonical Monte Carlo.

Authors:  Matteo Aldeghi; Gregory A Ross; Michael J Bodkin; Jonathan W Essex; Stefan Knapp; Philip C Biggin
Journal:  Commun Chem       Date:  2018-04-05

Review 9.  BET proteins: Investigating BRDT as a potential target for male contraception.

Authors:  Andrea Wisniewski; Gunda I Georg
Journal:  Bioorg Med Chem Lett       Date:  2020-01-21       Impact factor: 2.823

10.  Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.

Authors:  Michael D Olp; Nan Zhu; Brian C Smith
Journal:  Biochemistry       Date:  2017-10-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.